In vivo effects of endothelin‐2, endothelin‐3 and ETAreceptor blockade on arterial, venous and capillary functions in cat skeletal muscle
- 1 January 1994
- journal article
- research article
- Published by Wiley in Acta Physiologica Scandinavica
- Vol. 150 (1) , 47-56
- https://doi.org/10.1111/j.1748-1716.1994.tb09658.x
Abstract
Ekelund, U. 1994.In vivoeffects of endothelin‐2, endothelin‐3 and ETAreceptor blockade on arterial, venous and capillary functions in cat skeletal muscle.Acta Physiol Scand150, 47–56. Received 31 March 1993, accepted 25 May 1993. ISSN 0001–6772. Department of Physiology & Biophysics, University of Lund, Sweden.This study describes, in quantitative terms, the effects of endothelin‐2 and endothelin‐3 on vascular tone (resistance) in large‐bore arterial resistance vessels (> 25 /μm), small arterioles (< 25 μm) and the veins, as well as on capillary pressure and fluid exchange in cat gastrocnemius musclein vivo.Infusion of endothelin‐2 or endothelin‐3 (200–1600 ng kg‐1min‐1, i.a.) elicited an initial transient dilation, followed by a dose‐dependent, slowly developing constrictor response, being maintained after cessation of the infusion. At the dose of 400 ng kg‐1min‐1(n= 9), infused i.a. during 20 min, endothelin‐2 caused an average increase in total regional vascular resistance of 80%, and endothelin‐3 of 35%, and the site of constrictor action of both peptides was preferentially located to the small arterioles. Endothelin‐2 also constricted the veins and, hence, evoked a pronounced capacitance response, whereas endothelin‐3 was devoid of any venoconstrictor effect. This difference, via effects on the pre‐/post‐capillary resistance ratio, led to a more pronounced fall of capillary pressure in response to endothelin‐3 than to endothelin‐2. The new specific competitive ETAreceptor antagonist, FR 139317, abolished the vasoconstrictor response to both endothelin‐2 and endothelin‐3in vivo,whereas the preceding vasodilator responses were unaffected. These results, taken together with those of our previous analogous study of the effects of endothelin‐1, indicated that all three endothelins were approximately equally as effective in eliciting the transient dilator response in skeletal musclein vivo,whereas the order of vasoconstrictor activity was endothelin‐1 > endothelin‐2 > endothelin‐3. Due to an especially pronounced venoconstrictor activity of endothelin‐1, this peptide, in contrast to endothelin‐2 and ‐3, evoked a rise in capillary pressure, with a consequent net transcapillary fluid filtration and muscle tissue oedema formation. The results further indicated that the vasoconstrictor responses to all endothelins in skeletal muscle were mediated by the ETAreceptor, whereas the initial transient vasodilator responses seemed to be mediated by the ETBreceptor.Keywords
This publication has 23 references indexed in Scilit:
- In‐vivoeffects of endothelin‐1 and ETareceptor blockade on arterial, venous and capillary functions in skeletal muscleActa Physiologica Scandinavica, 1993
- Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissueJournal Of Hypertension, 1992
- Myogenic vascular regulation in skeletal muscle in vivo is not dependent of endothelium‐derived nitric oxideActa Physiologica Scandinavica, 1992
- Cross tachyphylaxis to endothelin isopeptide‐induced hypotension: a phenomenon not seen with proendothelinBritish Journal of Pharmacology, 1991
- Role of endothelium‐derived nitric oxide in the regulation of tonus in large‐bore arterial resistance vessels, arterioles and veins in cat skeletal muscleActa Physiologica Scandinavica, 1990
- Regional haemodynamic effects of endothelin-1 in rat and man: unexpected adverse reactionsJournal Of Hypertension, 1990
- Regional haemodynamic effects of endothelin‐1 and endothelin‐3 in conscious Long Evans and Brattleboro ratsBritish Journal of Pharmacology, 1990
- Synthesis of the vasoconstrictor peptide endothelin in kidney cellsFEBS Letters, 1989
- The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.Proceedings of the National Academy of Sciences, 1989
- Site of autoregulatory reactions in the vascular bed of cat skeletal muscle as determined with a new technique for segmental vascular resistance recordingsActa Physiologica Scandinavica, 1988